Home › Trial NCT02598219
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.
- Trial IDNCT02598219
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorCentre Oscar Lambret
- Enrollment262
- Start date2015-11-19
- ConditionsNon Endometrioid Carcinoma · Endometrioid Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.